Diagnosis and management of eosinophilic otitis media: a systematic review

Abstract Background Eosinophilic Otitis Media (EOM) is a relatively newly defined entity of recurrent and resistant otitis media. Objective To perform a systematic review of otologic manifestations, diagnosis and management of eosinophilic otitis media (EOM). Methods 393 patients diagnosed with EOM of 26 studies met inclusion criteria and were assessed for demographics, otologic manifestations, diagnostic criteria fulfilled, and medical and surgical treatments. Results Most common otologic manifestations were hearing loss (65%), otitis media with effusion (16%), tympanic membrane perforation (13%), and otorrhea (13%). 93% had a predominantly eosinophilic middle ear effusion, 95% had asthma, 85% had a highly viscous middle ear effusion, 71% had nasal polyposis, and 58% had resistance to conventional treatment. For treatment, 39% received intratympanic steroid injections, 33% received systemic steroids, 17% received steroid ear drops and 13% received a biological agent. 39% of patients underwent a surgical intervention with 26% receiving functional endoscopic sinus surgery and 18% receiving myringotomy with tube insertion. Success rates were highest with use of intratympanic steroids (45%), systemic steroids (26%), and biological agents (58%). Conclusion Intratympanic steroids show the most efficacy in treating EOM, and aggressive optimization of asthma may be beneficial in resolving otologic symptoms. Surgery should be reserved for refractory cases and complications.

[1]  K. Chow,et al.  Use of IL-5 Inhibitor Benralizumab as a Novel Therapy for Eosinophilic Otitis Media: Clinical Capsule and Review of Literature. , 2020, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[2]  A. Homma,et al.  Differentiation Between Eosinophilic Otitis Media and Otitis Media Associated With Eosinophilic Granulomatosis With Polyangiitis. , 2019, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[3]  Y. Iino,et al.  Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media. , 2019, Auris, nasus, larynx.

[4]  A. Tanaka,et al.  Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab. , 2019, Auris, nasus, larynx.

[5]  N. Yoshida,et al.  Proposal of a Treatment Strategy for Eosinophilic Otitis Media Based on Middle Ear Condition. , 2018, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[6]  M. Park,et al.  Eosinophilic Otitis Media Treated with Anti-IgE Monoclonal Antibodies and A Bone Conduction Implant. , 2018, The journal of international advanced otology.

[7]  I. Saliba,et al.  Eosinophilic otitis media diagnosis using flow cytometric immunophenotyping , 2018, Acta oto-laryngologica.

[8]  R. Pawankar,et al.  Optimal control of asthma improved eosinophilic otitis media , 2018, Asia Pacific allergy.

[9]  M. Carlson,et al.  Treatment of eosinophilic otitis media with pegylated interferon‐α 2a and 2b , 2017, The Laryngoscope.

[10]  R. Yağız,et al.  A case of intractable otitis media: eosinophilic otitis media. , 2014, Balkan medical journal.

[11]  N. Yoshida,et al.  Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media , 2014, Acta oto-laryngologica.

[12]  R. Pawankar,et al.  Improvement of Eosinophilic Otitis Media by Optimized Asthma Treatment , 2013, Allergy, asthma & immunology research.

[13]  N. Yoshida,et al.  Clinical Efficacy of Anti-IgE Therapy for Eosinophilic Otitis Media , 2012, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[14]  Jeong Hyun Lee,et al.  Eosinophilic Otitis Media: CT and MRI Findings and Literature Review , 2012, Korean journal of radiology.

[15]  T. Nakagawa,et al.  Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease. , 2011, Auris, nasus, larynx.

[16]  H. Kojima,et al.  Cochlear implantation in patients with chronic otitis media. , 2010, Auris, nasus, larynx.

[17]  K. Kodera,et al.  Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[18]  S. Iwasaki,et al.  Cochlear implantation in a patient with eosinophilic otitis media , 2006, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[19]  R. Stokroos,et al.  [Eosinophilic otitis media]. , 2014, Nederlandsch tijdschrift voor geneeskunde.